Baidu
map

AAOS 2013:抑郁与全关节置换术(TJA)术后并发症风险增加有关

2013-04-04 MedSci MedSci原创

  根据周二(2013年3月19日)报告的研究数据显示,抑郁与全关节置换术(TJA)术后并发症风险增加有关,包括术后精神异常、贫血、肺栓塞(PE)和感染。研究还发现TJA患者中抑郁的诊断在增加。   作者强调,虽然就抑郁对TJA术后疼痛缓解和功能恢复的影响已有过研究,但是对于抑郁对术后并发症发生率和死亡率的影响知之甚少。他们尝试评估TJA患者中抑郁的诊断率,并确定其对于早期转归的影响。    

  根据周二(2013年3月19日)报告的研究数据显示,抑郁与全关节置换术(TJA)术后并发症风险增加有关,包括术后精神异常、贫血、肺栓塞(PE)和感染。研究还发现TJA患者中抑郁的诊断在增加。

  作者强调,虽然就抑郁对TJA术后疼痛缓解和功能恢复的影响已有过研究,但是对于抑郁对术后并发症发生率和死亡率的影响知之甚少。他们尝试评估TJA患者中抑郁的诊断率,并确定其对于早期转归的影响。

   资料收集

  报告人 James A. Browne医学博士与来自弗吉尼亚大学的同事们,采用ICD-9-CM诊断及操作编码,对全国住院患者样本(NIS)数据库中于1998到2008年间接受过全髋关节置换术(THA)或全膝关节置换术(TKA)的患者进行分析。对其中在2006年到2008年接受过THA 或TKA的497222名患者进行详细分析。

  “我们采用NIS数据库,观察1998-2008年间接受髋关节和膝关节置换的患者,抑郁诊断率的变化。并仅对2006至2008年间的样本进行了着重分析”,Bowne医师解释道:“这为我们提供了大约500,000名近期的患者样本进行研究,我们相信这更贴近现今的实际情况”。

  这497,222名患者包含305,791名女性及191,431 名男性,平均年龄为64岁,其中61.5%曾接受过TKA,38.5%曾接受过HA。多数患者为白人(85%),主要的支付方式为医疗保险(55%)。

  根据美国医疗保健研究和质量管理局对抑郁共病的评价方法,约有10%的患者被认为处于抑郁状态。研究者采用多元回归分析比较了抑郁发生率与TJA术后的院内并发症、死亡率之间的关系。还对住院天数和总体费用进行了分析。

  抑郁增加并发症风险

  研究人员发现TJA患者中抑郁的诊断率由1998年的2.8%稳定增加至2008年的11.1%。多元分析显示TJA患者中的抑郁患者较非抑郁患者年轻(分别为63岁和66岁, P < 0.001),其中,显著的以白人、女性及以医疗保险为主要支付方式的患者居多(均为 P < 0.05)。

  抑郁患者的共病负担高于非抑郁患者。在经分析的术后并发症中,抑郁与更高的院内术后精神异常、贫血、PE和感染风险独立相关。抑郁与院内死亡率不相关。有趣的是,抑郁与较低的心脏和胃肠道并发症风险相关。抑郁患者与非抑郁患者的住院天数及住院费用接近。

  “我们的资料显示,抑郁的诊断与TJA术后并发症风险的增加有关,这一信息非常重要,尤其在为有精神病史的患者进行会诊时,或在术前进行鉴别时,某些患者或许能从抑郁预防治疗中获益。”,Browne医师说:“我们还相信,对患者转归数据风险调整时这一信息是非常重要的。需要进一步的研究来确认这些发现,及发现能够解释这些相关性的潜在作用机制”。

  原文地址:http://www.aaos.org/news/acadnews/2013/AAOS10_3_20.asp

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1742233, encodeId=42011e4223311, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Sun May 19 00:29:00 CST 2013, time=2013-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757558, encodeId=94671e5755856, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Sep 24 22:29:00 CST 2013, time=2013-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071158, encodeId=1c2c20e115878, content=<a href='/topic/show?id=ab241680a3' target=_blank style='color:#2F92EE;'>#AAO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1680, encryptionId=ab241680a3, topicName=AAO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 19 01:29:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754122, encodeId=5cb41e5412222, content=<a href='/topic/show?id=7d3330135ac' target=_blank style='color:#2F92EE;'>#关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30135, encryptionId=7d3330135ac, topicName=关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=050736663344, createdName=apoenzyme, createdTime=Tue Nov 12 08:29:00 CST 2013, time=2013-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642837, encodeId=4fe9164283eaa, content=<a href='/topic/show?id=1e19168181' target=_blank style='color:#2F92EE;'>#AAOS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1681, encryptionId=1e19168181, topicName=AAOS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c11e23034343, createdName=ms1260584454294838, createdTime=Wed Nov 20 14:29:00 CST 2013, time=2013-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373745, encodeId=ad4d13e37452a, content=<a href='/topic/show?id=e79129306cf' target=_blank style='color:#2F92EE;'>#全关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29306, encryptionId=e79129306cf, topicName=全关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56ea361, createdName=changhe713, createdTime=Sat Apr 06 10:29:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576457, encodeId=c0d515e64573b, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Sat Apr 06 10:29:00 CST 2013, time=2013-04-06, status=1, ipAttribution=)]
    2013-05-19 yxch48
  2. [GetPortalCommentsPageByObjectIdResponse(id=1742233, encodeId=42011e4223311, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Sun May 19 00:29:00 CST 2013, time=2013-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757558, encodeId=94671e5755856, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Sep 24 22:29:00 CST 2013, time=2013-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071158, encodeId=1c2c20e115878, content=<a href='/topic/show?id=ab241680a3' target=_blank style='color:#2F92EE;'>#AAO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1680, encryptionId=ab241680a3, topicName=AAO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 19 01:29:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754122, encodeId=5cb41e5412222, content=<a href='/topic/show?id=7d3330135ac' target=_blank style='color:#2F92EE;'>#关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30135, encryptionId=7d3330135ac, topicName=关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=050736663344, createdName=apoenzyme, createdTime=Tue Nov 12 08:29:00 CST 2013, time=2013-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642837, encodeId=4fe9164283eaa, content=<a href='/topic/show?id=1e19168181' target=_blank style='color:#2F92EE;'>#AAOS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1681, encryptionId=1e19168181, topicName=AAOS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c11e23034343, createdName=ms1260584454294838, createdTime=Wed Nov 20 14:29:00 CST 2013, time=2013-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373745, encodeId=ad4d13e37452a, content=<a href='/topic/show?id=e79129306cf' target=_blank style='color:#2F92EE;'>#全关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29306, encryptionId=e79129306cf, topicName=全关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56ea361, createdName=changhe713, createdTime=Sat Apr 06 10:29:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576457, encodeId=c0d515e64573b, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Sat Apr 06 10:29:00 CST 2013, time=2013-04-06, status=1, ipAttribution=)]
    2013-09-24 丁鹏鹏
  3. [GetPortalCommentsPageByObjectIdResponse(id=1742233, encodeId=42011e4223311, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Sun May 19 00:29:00 CST 2013, time=2013-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757558, encodeId=94671e5755856, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Sep 24 22:29:00 CST 2013, time=2013-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071158, encodeId=1c2c20e115878, content=<a href='/topic/show?id=ab241680a3' target=_blank style='color:#2F92EE;'>#AAO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1680, encryptionId=ab241680a3, topicName=AAO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 19 01:29:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754122, encodeId=5cb41e5412222, content=<a href='/topic/show?id=7d3330135ac' target=_blank style='color:#2F92EE;'>#关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30135, encryptionId=7d3330135ac, topicName=关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=050736663344, createdName=apoenzyme, createdTime=Tue Nov 12 08:29:00 CST 2013, time=2013-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642837, encodeId=4fe9164283eaa, content=<a href='/topic/show?id=1e19168181' target=_blank style='color:#2F92EE;'>#AAOS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1681, encryptionId=1e19168181, topicName=AAOS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c11e23034343, createdName=ms1260584454294838, createdTime=Wed Nov 20 14:29:00 CST 2013, time=2013-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373745, encodeId=ad4d13e37452a, content=<a href='/topic/show?id=e79129306cf' target=_blank style='color:#2F92EE;'>#全关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29306, encryptionId=e79129306cf, topicName=全关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56ea361, createdName=changhe713, createdTime=Sat Apr 06 10:29:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576457, encodeId=c0d515e64573b, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Sat Apr 06 10:29:00 CST 2013, time=2013-04-06, status=1, ipAttribution=)]
    2013-11-19 yinhl1978
  4. [GetPortalCommentsPageByObjectIdResponse(id=1742233, encodeId=42011e4223311, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Sun May 19 00:29:00 CST 2013, time=2013-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757558, encodeId=94671e5755856, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Sep 24 22:29:00 CST 2013, time=2013-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071158, encodeId=1c2c20e115878, content=<a href='/topic/show?id=ab241680a3' target=_blank style='color:#2F92EE;'>#AAO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1680, encryptionId=ab241680a3, topicName=AAO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 19 01:29:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754122, encodeId=5cb41e5412222, content=<a href='/topic/show?id=7d3330135ac' target=_blank style='color:#2F92EE;'>#关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30135, encryptionId=7d3330135ac, topicName=关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=050736663344, createdName=apoenzyme, createdTime=Tue Nov 12 08:29:00 CST 2013, time=2013-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642837, encodeId=4fe9164283eaa, content=<a href='/topic/show?id=1e19168181' target=_blank style='color:#2F92EE;'>#AAOS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1681, encryptionId=1e19168181, topicName=AAOS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c11e23034343, createdName=ms1260584454294838, createdTime=Wed Nov 20 14:29:00 CST 2013, time=2013-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373745, encodeId=ad4d13e37452a, content=<a href='/topic/show?id=e79129306cf' target=_blank style='color:#2F92EE;'>#全关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29306, encryptionId=e79129306cf, topicName=全关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56ea361, createdName=changhe713, createdTime=Sat Apr 06 10:29:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576457, encodeId=c0d515e64573b, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Sat Apr 06 10:29:00 CST 2013, time=2013-04-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1742233, encodeId=42011e4223311, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Sun May 19 00:29:00 CST 2013, time=2013-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757558, encodeId=94671e5755856, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Sep 24 22:29:00 CST 2013, time=2013-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071158, encodeId=1c2c20e115878, content=<a href='/topic/show?id=ab241680a3' target=_blank style='color:#2F92EE;'>#AAO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1680, encryptionId=ab241680a3, topicName=AAO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 19 01:29:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754122, encodeId=5cb41e5412222, content=<a href='/topic/show?id=7d3330135ac' target=_blank style='color:#2F92EE;'>#关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30135, encryptionId=7d3330135ac, topicName=关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=050736663344, createdName=apoenzyme, createdTime=Tue Nov 12 08:29:00 CST 2013, time=2013-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642837, encodeId=4fe9164283eaa, content=<a href='/topic/show?id=1e19168181' target=_blank style='color:#2F92EE;'>#AAOS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1681, encryptionId=1e19168181, topicName=AAOS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c11e23034343, createdName=ms1260584454294838, createdTime=Wed Nov 20 14:29:00 CST 2013, time=2013-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373745, encodeId=ad4d13e37452a, content=<a href='/topic/show?id=e79129306cf' target=_blank style='color:#2F92EE;'>#全关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29306, encryptionId=e79129306cf, topicName=全关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56ea361, createdName=changhe713, createdTime=Sat Apr 06 10:29:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576457, encodeId=c0d515e64573b, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Sat Apr 06 10:29:00 CST 2013, time=2013-04-06, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1742233, encodeId=42011e4223311, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Sun May 19 00:29:00 CST 2013, time=2013-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757558, encodeId=94671e5755856, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Sep 24 22:29:00 CST 2013, time=2013-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071158, encodeId=1c2c20e115878, content=<a href='/topic/show?id=ab241680a3' target=_blank style='color:#2F92EE;'>#AAO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1680, encryptionId=ab241680a3, topicName=AAO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 19 01:29:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754122, encodeId=5cb41e5412222, content=<a href='/topic/show?id=7d3330135ac' target=_blank style='color:#2F92EE;'>#关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30135, encryptionId=7d3330135ac, topicName=关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=050736663344, createdName=apoenzyme, createdTime=Tue Nov 12 08:29:00 CST 2013, time=2013-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642837, encodeId=4fe9164283eaa, content=<a href='/topic/show?id=1e19168181' target=_blank style='color:#2F92EE;'>#AAOS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1681, encryptionId=1e19168181, topicName=AAOS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c11e23034343, createdName=ms1260584454294838, createdTime=Wed Nov 20 14:29:00 CST 2013, time=2013-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373745, encodeId=ad4d13e37452a, content=<a href='/topic/show?id=e79129306cf' target=_blank style='color:#2F92EE;'>#全关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29306, encryptionId=e79129306cf, topicName=全关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56ea361, createdName=changhe713, createdTime=Sat Apr 06 10:29:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576457, encodeId=c0d515e64573b, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Sat Apr 06 10:29:00 CST 2013, time=2013-04-06, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1742233, encodeId=42011e4223311, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Sun May 19 00:29:00 CST 2013, time=2013-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757558, encodeId=94671e5755856, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Sep 24 22:29:00 CST 2013, time=2013-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071158, encodeId=1c2c20e115878, content=<a href='/topic/show?id=ab241680a3' target=_blank style='color:#2F92EE;'>#AAO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1680, encryptionId=ab241680a3, topicName=AAO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 19 01:29:00 CST 2013, time=2013-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754122, encodeId=5cb41e5412222, content=<a href='/topic/show?id=7d3330135ac' target=_blank style='color:#2F92EE;'>#关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30135, encryptionId=7d3330135ac, topicName=关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=050736663344, createdName=apoenzyme, createdTime=Tue Nov 12 08:29:00 CST 2013, time=2013-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642837, encodeId=4fe9164283eaa, content=<a href='/topic/show?id=1e19168181' target=_blank style='color:#2F92EE;'>#AAOS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1681, encryptionId=1e19168181, topicName=AAOS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c11e23034343, createdName=ms1260584454294838, createdTime=Wed Nov 20 14:29:00 CST 2013, time=2013-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373745, encodeId=ad4d13e37452a, content=<a href='/topic/show?id=e79129306cf' target=_blank style='color:#2F92EE;'>#全关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29306, encryptionId=e79129306cf, topicName=全关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56ea361, createdName=changhe713, createdTime=Sat Apr 06 10:29:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576457, encodeId=c0d515e64573b, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Sat Apr 06 10:29:00 CST 2013, time=2013-04-06, status=1, ipAttribution=)]

相关资讯

Stroke:卒中后抑郁症长期复发风险高

  英国一项研究表明,卒中后抑郁症的自然史是动态的。抑郁影响大部分卒中患者,抑郁症状持续时间短但长期复发风险高。该研究论文近期发表于《卒中》(Stroke)杂志。   该研究收集了伦敦南部卒中注册数据库中1995~2009年的患者数据(共4022例,本研究分析1233例)。   研究在卒中后3个月、1年和此后每年(共15年),对所有患者采用医院焦虑和抑郁量表(评分≥7分为抑郁)进行抑郁评估,采

Eur J Endocrinol: 1型糖尿病患者HbA1c水平过高能直接导致抑郁

  瑞典一项研究表明,抑郁与1型糖尿病患者糖化血红蛋白(HbA1c)水平>8.6%独立相关。这种相关性与血糖控制不佳和糖尿病并发症的已知风险因素肥胖和吸烟的重要性具有可比性。抑郁与HbA1c水平>8.6%的相关性在女性当中尤其明显。述情障碍(alexithymia)是一种相对稳定的个性特征,与抑郁相关。今后,在糖尿病患者的护理中,为了使HbA1c达标,应将精神因素与人体测量学(anthropome

ABEM:抑郁治疗可改善糖尿病人体力活动

  一项新的研究表明增强2型糖尿病患者独立性和治疗其抑郁症状可以促进患者体力活动能力提高。集体活动和来自看护人员与患者家庭的支持可能对依赖性较强的患者有益,也可促使平时体力活动较少的2型糖尿病患者参与到锻炼计划中。   为评估2型糖尿病患者体力活动、并发症、抑郁症状和健康相关生活质量之间的联系,研究者纳入200例2型糖尿病患者及50例对照者,所有受试者年龄均在40-60岁之间。通过国际体力活动量

Health Psychol:临床确诊糖尿病者抑郁风险增加

  最近发表于《健康心理学》杂志上的一项研究表明,对于糖尿病与抑郁症的关系,以及是否给患者服用抗抑郁药最重要的决定因素在于糖尿病是否已经临床诊断。   研究旨在评估临床诊断及未诊断的糖尿病前期与合并抑郁的2型糖尿病和抗抑郁药使用的联系。研究数据来自全国健康营养调查(2005年和2007年),这是一项基于人群的横断面调查。所有受试者均为30岁及以上的成年人(3183例,平均年龄52.1岁)。抑郁症

PDS:抗抑郁药降低糖尿病人服药依从性

  一项回顾性研究显示抑郁可能与糖尿病患者服药依从性差有关,合并抑郁症的糖尿病患者需要更多合理用药指导。研究于2013年2月28日在线发表在《药物流行病学和药品安全》杂志。   研究旨在观察抗抑郁药是否会对老年人坚持服用口服降糖药产生影响。研究者收集来自澳大利亚退伍军人事务部的数据,即2000年7月1日到2008年6月30日期间开始口服降糖药(二甲双胍或磺脲类药物)的患者。抗抑郁药在首次服用降糖

SGO2013:心理素质高可改善卵巢癌预后

  2013年3月10日在美国洛杉矶召开的妇科肿瘤学会(SGO)妇科肿瘤年会上,来自圣路易斯华盛顿大学医学院的Premal Thaker博士及其同事发布了他们最新的一项研究结果:心理素质(Spirituality)高的卵巢癌患者,其抗压力、抗抑郁的能力较强,其某些调节肿瘤血管发生与炎症的因子预后值也较好。   Thaker博士在会议上报告,卵巢癌患者心理素质较高与其感受到的压力与

Baidu
map
Baidu
map
Baidu
map